J&J invests in “cell-free” cartilage repair technology

JNJ LEADS $15 MILLION FUNDING FOR INNOVATIVE CARTILAGE TECHNOLOGY (Orthopedics This Week)
website.. http://www.cartiheal.com/
Johnson & Johnson Innovation (JJDC investors) joins a blue chip list of venture investors including Elron, Accelmed, Access Medical Ventures, and Peregrine Ventures to fund an innovative cartilage repair technology called Agili-C and a promising young Israeli company named CartiHeal, Ltd.
Agili-C, the technology that has attracted these top venture investors, is a calcium carbonite and HA (hyaluronic acid) implant that has been shown in several post-marketing studie...